Enhanced notification of infusion pump programming errors

Studies in Health Technology and Informatics

Volumn 160, Issue PART 1, 2010, Pages 734-738

  Scott Evans, R ^a,b   Carlson, Rick ^c   Johnson, Kyle V ^a   Palmer, Brent K ^c   Lloyd, James F ^a  

^a Intermountain Health Care ^*  (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^c INTERMOUNTAIN MEDICAL CENTER   (United States)

Author keywords

Adverse drug events; Infusion pumps; Patient harm

Indexed keywords

ARTIFICIAL INTELLIGENCE; DRUG DOSAGE; DRUG INFUSION; ERRORS; HOSPITAL DATA PROCESSING; MEDICAL COMPUTING;

ACCEPTABLE LIMIT; ADVERSE DRUG EVENTS; ELECTRONIC MEDICAL RECORD; INFUSION PUMP; MEDICATION ERRORS; PATIENT HARM; POTENTIAL HARM; PROGRAMMING ERRORS;

PUMPS;

EID: 78649527547     PISSN: 09269630     EISSN: 18798365     Source Type: Conference Proceeding    
DOI: 10.3233/978-1-60750-588-4-734     Document Type: Conference Paper

References (15)

1. Husch M, Sullivan C, Rooney D, et al. Insights from the sharp end of intravenous medication errors: Implications for infusion pump technology. Qual Saf Health Care. 2005;14:80-6.
2. Eskew JA, Jacobi J, Buss WF, et al. Using innovative technologies to set new safety standards for the infusion of intravenous medication. Hosp Pharm 2002;37:1179-89.
3. Leape LL, Bennan TA, Laird N, et al. The nature of adverse events in hospitalized patients. Results of the Harvard Medical Practice Study II. N Engl J Med 1991;324:377-84.
4. Bates DW, Cullen DJ, Laird N, et al. Incidence of adverse drug events and potential adverse drug events. Implications for prevention. JAMA 1995;274:29-43.
5. Institute of Medicine. Preventing medication errors: quality chasm series. Washington, DC: National Academy Press, 2006.
6. Malashock CM, Shull SS, Gould DA. Effect of smart infusion pumps on medication errors related to infusion device programming. Hosp Pharm 2004;39:460-469.
7. Apkon M, Leonard J, Probst L, et al. Design of a safer approach to intravenous drug infusions: failure mode effects analysis. Qual Saf Health Care 2004;13:265-7.
8. Rosenthal K. Smart pumps help crack the safety code. Nurs Manage 2004;35:49.
9. Adachi W, Lodolce AE. Use of failure mode and effects analysis in improving the safety of i.v. drug administration Am J Health Syst 2004;62; 917.
10. Rothschild j, Keohane C, Cook E, et al. A controlled trial of smart infusion pumps to improve medication safety in critically ill patients. Crit Care Med 2005;33:533-540.
11. Nuckols TK, Bower AG, Paddock SM, et al. Programmable infusion pumps in ICUs: An analysis of corresponding adverse drug events. J Gen Intern Med 2008;23(suppl 1):41-5
12. Larsen GY, Parker HB, Cash J, et al. Standard drug concentrations and smart-pump technology reduce continuous-medication infusion errors in pediatric patients. Pediatrics 2005;116: e21-e25.
13. Wilson K, Sullivan M. Preventing medication errors with smart infusion technology. Am J Health Syst Pharm 2004;61; 177-83.
14. Murdoch LJ, Cameron VL. Smart technology: a minimum safety standard for intensive care? B r J Nurs 2008;17:630-6.
15. Fanikos J, Fiumara K, Baroletti, et al. Impact of smart infusion technology on administration of anticoagulants (unfractionated heparin, argatroban, lepirudin and bivalirudin. Am J Cardiol 2007;99:1002-5.